These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14651423)

  • 1. Areas of decrement in health-related quality of life (HRQL): comparing the SF-12, EQ-5D, and HUI 3.
    Lubetkin EI; Gold MR
    Qual Life Res; 2003 Dec; 12(8):1059-67. PubMed ID: 14651423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construct validity of the EQ-5D in low-income Chinese American primary care patients.
    Lubetkin EI; Jia H; Gold MR
    Qual Life Res; 2004 Oct; 13(8):1459-68. PubMed ID: 15503841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.
    Tawiah AK; Al Sayah F; Ohinmaa A; Johnson JA
    Health Qual Life Outcomes; 2019 Apr; 17(1):68. PubMed ID: 30995930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Health Utility Index (HUI) for measuring the impact on health-related quality of Life (HRQL) among individuals with chronic diseases.
    Mo F; Choi BC; Li FC; Merrick J
    ScientificWorldJournal; 2004 Aug; 4():746-57. PubMed ID: 15349514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
    Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ
    Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) participants.
    McDonough CM; Grove MR; Tosteson TD; Lurie JD; Hilibrand AS; Tosteson AN
    Qual Life Res; 2005 Jun; 14(5):1321-32. PubMed ID: 16047507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instruments.
    Szende A; Schramm W; Flood E; Larson P; Gorina E; Rentz AM; Snyder L
    Haemophilia; 2003 Nov; 9(6):678-87. PubMed ID: 14750933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of health utility measures for the evaluation of multiple sclerosis treatments.
    Fisk JD; Brown MG; Sketris IS; Metz LM; Murray TJ; Stadnyk KJ
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):58-63. PubMed ID: 15607996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments.
    Suarez-Almazor ME; Kendall C; Johnson JA; Skeith K; Vincent D
    Rheumatology (Oxford); 2000 Jul; 39(7):783-90. PubMed ID: 10908699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EQ-5D in a general population survey--a description of the most commonly reported EQ-5D health states using the SF-36.
    Nordlund A; Ekberg K; Kristenson M
    Qual Life Res; 2005 May; 14(4):1099-109. PubMed ID: 16041905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness.
    Haywood KL; Garratt AM; Dziedzic K; Dawes PT
    Rheumatology (Oxford); 2002 Dec; 41(12):1380-7. PubMed ID: 12468817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
    Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
    Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariable Regression Model of the EuroQol 5-Dimension Questionnaire in Patients Seeking Outpatient Low Vision Rehabilitation.
    Malkin AG; Goldstein JE; Massof RW
    Ophthalmic Epidemiol; 2017 Jun; 24(3):174-180. PubMed ID: 28045563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of utility measures for women with urge, stress, and mixed urinary incontinence.
    Harvie HS; Shea JA; Andy UU; Propert K; Schwartz JS; Arya LA
    Am J Obstet Gynecol; 2014 Jan; 210(1):85.e1-6. PubMed ID: 24055585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the EQ-5D in patients with a history of acute coronary syndrome.
    Ellis JJ; Eagle KA; Kline-Rogers EM; Erickson SR
    Curr Med Res Opin; 2005 Aug; 21(8):1209-16. PubMed ID: 16083530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
    Park SJ; Ahn S; Woo SJ; Park KH
    JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison.
    Oostenbrink R; A Moll HA; Essink-Bot ML
    J Clin Epidemiol; 2002 Aug; 55(8):791-9. PubMed ID: 12384194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.